Cargando…

Natural history of PF4 antibodies in vaccine-induced immune thrombocytopenia and thrombosis

The COVID-19 pandemic has resulted in the rapid development of a range of vaccines against SARS-CoV-2. Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is a rare but life-threatening complication of primarily adenoviral-based vaccines associated with the presence of antibodies to a PF4/...

Descripción completa

Detalles Bibliográficos
Autores principales:	Craven, Brian, Lester, William, Boyce, Sara, Thomas, Will, Kanny, Angela, Davies, Claire, Pavord, Sue, Hermans, Joannes, Makris, Michael, Bart-Smith, Emily, Arnott, Sarah, Hunt, Beverley J., Chudakou, Pavel, Calvert, Anthony, Singh, Deepak, Scully, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology. 2022
Materias:	Thrombosis and Hemostasis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912978/ https://www.ncbi.nlm.nih.gov/pubmed/35263420 http://dx.doi.org/10.1182/blood.2021014684

Ejemplares similares

Second-dose VITT: rare but real
por: Pavord, Sue, et al.
Publicado: (2022)

Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient
por: Schönborn, Linda, et al.
Publicado: (2022)

The prevalence of thrombocytopenia in patients with acute cancer-associated thrombosis
por: Hsu, Charles, et al.
Publicado: (2022)

Inhibition of NADPH oxidase blocks NETosis and reduces thrombosis in heparin-induced thrombocytopenia
por: Leung, Halina H. L., et al.
Publicado: (2021)

Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic?
por: Sarkar, Amrita, et al.
Publicado: (2023)

Vaccine‐induced Immune Thrombocytopenia and Thrombosis (VITT)
por: Makris, Michael, et al.
Publicado: (2021)

Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study
por: Crobach, Monique J. T., et al.
Publicado: (2023)

The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia
por: Bissola, Anna-Lise, et al.
Publicado: (2022)

Cost-effectiveness analysis of alternative anticoagulation in suspected heparin-induced thrombocytopenia
por: Tuleja, Aleksandra, et al.
Publicado: (2022)

CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy
por: Cordero-Sanchez, Celia, et al.
Publicado: (2022)

Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study
por: Carney, Brian J., et al.
Publicado: (2021)

Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia
por: Ilich, Anton, et al.
Publicado: (2022)

COVID-19 coagulopathy, thrombosis, and bleeding
por: Chan, Noel C., et al.
Publicado: (2020)

Racial disparities in cancer-associated thrombosis
por: Datta, Tatini, et al.
Publicado: (2022)

Histidine-rich glycoprotein attenuates catheter thrombosis
por: Malik, Rida A., et al.
Publicado: (2023)

A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia
por: Lee, Christine S.M., et al.
Publicado: (2022)

ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia
por: Karnes, Jason H., et al.
Publicado: (2022)

The incidence of cancer-associated thrombosis is increasing over time
por: Mahajan, Anjlee, et al.
Publicado: (2022)

Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C
por: Whitworth, Hilary, et al.
Publicado: (2021)

Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis
por: Candeloro, Matteo, et al.
Publicado: (2022)

Impaired exercise capacity in post–COVID-19 syndrome: the role of VWF-ADAMTS13 axis
por: Prasannan, Nithya, et al.
Publicado: (2022)

A toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies
por: Siegal, Deborah M., et al.
Publicado: (2020)

The binding of autotaxin to integrins mediates hyperhomocysteinemia-potentiated platelet activation and thrombosis in mice and humans
por: Han, Lulu, et al.
Publicado: (2021)

Structure of shear-induced platelet aggregated clot formed in an in vitro arterial thrombosis model
por: Kim, Dongjune A., et al.
Publicado: (2022)

Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19
por: Wygrecka, Malgorzata, et al.
Publicado: (2022)

Thromboembolic events, bleeding, and mortality in patients with cerebral venous thrombosis: a nationwide cohort study
por: Skajaa, Nils, et al.
Publicado: (2022)

Impaired factor V–related anticoagulant mechanisms and deep vein thrombosis associated with A2086D and W1920R mutations
por: Shimonishi, Naruto, et al.
Publicado: (2023)

Alterations in B- and circulating T-follicular helper cell subsets in immune thrombotic thrombocytopenic purpura
por: Shin, Jin-Sup, et al.
Publicado: (2022)

Synonymous ADAMTS13 variants impact molecular characteristics and contribute to variability in active protein abundance
por: Jankowska, Katarzyna I., et al.
Publicado: (2022)

Small interfering RNA–mediated allele-selective silencing of von Willebrand factor in vitro and in vivo
por: Jongejan, Yvonne K., et al.
Publicado: (2023)

Structural, functional, and immunogenicity implications of F9 gene recoding
por: Katneni, Upendra K., et al.
Publicado: (2022)

Tumor-expressed factor VII is associated with survival and regulates tumor progression in breast cancer
por: Kroone, Chantal, et al.
Publicado: (2023)

Individual risk factors predictive of venous thromboembolism in patients with temporary lower limb immobilization due to injury: a systematic review
por: Horner, Daniel, et al.
Publicado: (2019)

The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies
por: Longstaff, Colin, et al.
Publicado: (2011)

Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain
por: Andersson, Helena M., et al.
Publicado: (2010)

Harmful or Physiologic: Diagnosing Fibrinolysis Shutdown in a Trauma Cohort With Rotational Thromboelastometry
por: Gomez-Builes, J. Carolina, et al.
Publicado: (2018)

Platelets inhibit apoptotic lung epithelial cell death and protect mice against infection-induced lung injury
por: Bain, William, et al.
Publicado: (2019)

Targeting complement activation in COVID-19
por: Kulkarni, Hrishikesh S., et al.
Publicado: (2020)

Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition
por: Yu, Jia, et al.
Publicado: (2020)

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
por: Al-Samkari, Hanny, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7e7qtu31i9h4up87l1hg24clqd